Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
1. Name of Investigational Products Huangkui capsule.
2. Trial Topic A Randomized, Double-blinded, Parallel, controlled, Multicenter Clinical
Trial of Huangkui Capsule in Treating Type II Diabetic Nephropathy (DKD)
3. Trial Objectives Primary objective:To evaluate HuangKui capsule efficacy for treatment
of type II diabetes ACR.
Secondary objective: To evaluate the efficacy of HuangKui capsule on 24-hour urinary
protein changes、reduce PCR-increase eGFR, improve micro-inflammatory state, and
improving Traditional Chinese medicine clinical efficacy
4. Trial Design Designed as a block randomized, double-blinded, parallel controlled,
multi-center clinical trial.